MeSH tree: E04.074
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools. While experts hope this will increase uptake in the under-screened population, a first-of-its kind study ...
Feb 6, 2026
0
7
Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical cancers.
Feb 3, 2026
0
6
Cancer screenings play a critical role in protecting long-term health. They can detect cancer early, when treatment is most effective, and in some cases help prevent cancer before it develops. While screening recommendations ...
Jan 29, 2026
0
5
New research led by King's College London suggests that a simple test already used in clinics could provide valuable additional insights into how the body's immune system responds to cancer, without requiring any extra procedures ...
Jan 29, 2026
0
14
Regular cervical cancer screening using HPV testing and/or Pap tests can prevent up to 90% or more of cervical cancers by detecting and treating precancerous lesions early, making it one of the most preventable cancers. Yet, ...
Jan 22, 2026
0
15
At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women lack confidence in their ability to complete the collection themselves.
Jan 20, 2026
0
13
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumor excision, surgeons often struggle to determine exactly how much tissue should be removed, ...
Jan 6, 2026
0
45
Women may soon have an easier, lower-cost way to get screened for cervical cancer.
Jan 6, 2026
0
9
Adherence to cervical cancer screening guidelines is low, with more than 60% undergoing overscreening, according to a research letter published online Dec. 10 in JAMA Network Open.
Dec 16, 2025
0
9
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median ...
Dec 11, 2025
0
10
